Clinical Trial Update: Perioperative Troponin I and NT Pro-BNP in Lung Resection

View source ↗

Summary

A completed clinical trial evaluating perioperative troponin I and NT-proBNP to assess cardiac risk in patients undergoing lung resection for thoracic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease
• Lung Cancer

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Cardiac Ischemia, Thoracic Cancer | Status: COMPLETED